China Pharma Holdings raises $10 million in financing
Net proceeds from the offering of approximately $9.3 million are expected to be used for expansion of the company’s existing product line, sales and marketing, and general working
Telix Pharmaceuticals has officially opened a radiopharmaceutical research, manufacturing, and treatment facility in Melbourne, Australia, to expedite the delivery of new treatments for cancer.